SAN ANTONIO — Long-term use of gabapentin enacarbil for treatment of restless leg syndrome does not lead to the symptom augmentation that commonly occurs with dopaminergic agents, a study shows.
From the Annual Meeting of the Associated Professional Sleep Societies
PREVIEW